Conmed (CNMD) Tops Q1 EPS by 5c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.79, $0.05 better than the analyst estimate of $0.74. Revenue for the quarter came in at $312.3 million versus the consensus estimate of $306.73 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.25-$4.35, versus the consensus of $4.33. Conmed sees FY2024 revenue of $1.33-1.355 billion, versus the consensus of $1.35 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- California Resources (CRC) Tops Q3 EPS by 21c
- Commercial Vehicle Group (CVGI) Tops Q3 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
